Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Doxorubicin for AIDS-Associated Kaposi's Sarcoma
NCT00000996Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in Kaposi's sarcoma (KS), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
doxorubicin
03
Conditions
Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT00000996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000996.